Pro-Dex, Inc. (NASDAQ: PDEX) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $198M. The Maz Rating grades it against the other companies in its sector.
Pro-Dex, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $61.93, Pro-Dex, Inc. trades at 16.6x trailing earnings, 2.5x sales and 4.0x book value, with an EV/EBITDA of 12.0. Over the last twelve months it generated about $80M of revenue and $12M of net income. It runs a gross margin of 32.5%, an operating margin of 16.8% and a net margin of 15.1%. It shows return on equity of 26.2%, return on invested capital of 15.5% and a free cash flow yield of 5.5%. On the balance sheet: a debt-to-equity ratio of 0.38 and a current ratio of 4.19. Over the past 52 weeks the share price ranged from $28.81 to $77.00, with a beta of 0.06.
Pro-Dex, Inc. does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.